To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome

Key facts

Sponsor

Staidson (Beijing) Biopharmaceuticals Co., Ltd

Principal Investigator

Bin M.D. Cao

China-Japan Friendship Hospital

Intervention

STSA-1002 injection(drug)

Enrollment

406 target

Eligibility

18-85 years · All sexes

Timeline

2025 – 2026

Study locations (15)

• China-Japan Friendship Hospital, Beijing, Beijing Municipality, China
• The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
• The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
• The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
• The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China
• The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China
• Henan Provincial People's Hospital, Zhengzhou, Henan, China
• The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
• Wuhan Central Hospital, Wuhan, Hubei, China
• Xiangtan Central Hospital, Xiangtan, Hunan, China
• The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
• Weifang People's Hospital, Weifang, Shandong, China
• Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan, China
• Dazhou Central Hospital, Dazhou, Sichuan, China
• Hangzhou First People's Hospital, Hangzhou, Zhejiang, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Acute lung injury

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT06526598
  Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) Trial
  Capital Medical University
• RECRUITINGNANCT07380789
  Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in Ukraine
  Lviv National Medical University
• RECRUITINGPHASE2, PHASE3NCT07342205
  A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation
  Shanghai University of Traditional Chinese Medicine
• RECRUITINGPHASE2NCT06513949
  Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients
  Implicit Bioscience
• RECRUITINGPHASE2NCT06703073
  JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
  PPD Development, LP
• RECRUITINGPHASE1, PHASE2NCT07413978
  A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress Syndrome
  Changchun Tuohua Pharmaceutical Co., Ltd.
• RECRUITINGNANCT06772025
  A Study to Understand How Cardiac Surgery-associated Acute Kidney Injury Develops in Participants Who Undergo Heart Surgery With the Use of Heart-lung Machine
  Bayer
• RECRUITINGNCT07100860
  The Effect of Single Lung Ventilation Duration on Postoperative Pulmonary Complications in Thoracic Surgery
  Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

See all trials for Acute lung injury →